Results 241 to 250 of about 55,423 (289)

Comparative Analysis of a Dual DNA–RNA Panel and a DNA‐Only Panel for Sarcoma: Real‐World Data From a Nationwide Genomic Database

open access: yesCancer Science, Volume 117, Issue 1, Page 156-168, January 2026.
Dual DNA–RNA panel with matched tumor–normal testing may improve diagnostic accuracy and inform treatment decisions in the routine clinical management of sarcoma. ABSTRACT Next‐generation sequencing‐based comprehensive cancer genomic profiling is promising in cancer management; however, most studies rely on tumor‐only DNA panels from single ...
Eiji Nakata   +10 more
wiley   +1 more source

Novel Methylation‐Based Model for Accurate Diagnosis of Upper Mediastinal Lymph Node Metastasis in Esophagogastric Junction Adenocarcinoma

open access: yesCancer Science, Volume 117, Issue 1, Page 169-180, January 2026.
DNA methylation‐based diagnostic model enables accurate, noninvasive identification of upper mediastinal lymph node metastasis and may guide personalized treatment strategies for patients with esophagogastric junction adenocarcinoma. ABSTRACT Even after surgical resection, the prognosis is poor for patients with esophagogastric junction adenocarcinoma ...
Yudai Higuchi   +14 more
wiley   +1 more source

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation

open access: yesCancer Science, Volume 117, Issue 1, Page 90-104, January 2026.
ZNF282 is a zinc finger protein overexpressed in colorectal cancer that facilitates tumor progression by promoting cell cycle progression via E2F1 activation. Our study demonstrates that ZNF282 expression is associated with poor prognosis and may serve as a novel prognostic biomarker and therapeutic target. ABSTRACT Colorectal cancer (CRC) is a leading
Tadashi Abe   +23 more
wiley   +1 more source

MOLECULAR ANALYSIS OF MICROSATELLITE INSTABILITY IN HEREDITARY NON POLYPOSIS COLON CARCINOMA PATIENTS FROM NORTH-EAST IRAN [PDF]

open access: green, 2009
Hamid Galehdari   +4 more
openalex  

A Robust Immunohistochemistry‐Based Classification for BRAF V600E‐Mutant Colorectal Cancer With Clinical Implications

open access: yesCancer Science, Volume 117, Issue 1, Page 246-256, January 2026.
This study develops an immunohistochemistry (IHC)‐based classification system for BRAF V600E‐mutant colorectal cancer, enabling practical stratification into iBM1 and iBM2 subtypes using CD8 and ARHGEF17 markers. The IHC‐defined subtypes demonstrated concordance with transcriptomic BM1/BM2 classifications and reflected distinct molecular and immune ...
Chao Liu   +11 more
wiley   +1 more source

Prognostic Biomarker of Fertility‐Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer

open access: yesCancer Science, Volume 117, Issue 1, Page 236-245, January 2026.
We identified prognostic biomarkers that predict treatment outcomes in patients receiving fertility‐preserving high‐dose medroxyprogesterone acetate (MPA) therapy through comprehensive multigene panel testing. ABSTRACT In this study, we identified prognostic biomarkers that predict treatment outcome in patients receiving fertility‐preserving high‐dose ...
Takuro Hirano   +10 more
wiley   +1 more source

A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model

open access: yesCancer Science, Volume 117, Issue 1, Page 8-18, January 2026.
We established and extensively analyzed an organoid‐based mouse model that closely mimics human pancreatic ductal adenocarcinoma. Monotherapy with an immune checkpoint inhibitor cocktail or a CD40 agonist antibody showed minimal efficacy. However, combining both reagents produced a strong synergistic effect by enhancing anti‐tumor immunity.
Juri Ichikawa   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy